Remove Documentation Remove Inpatient Remove Pharmaceutical Companies
article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

In an email to Pharmaceutical Technology , he further described the therapy as “the most important advance for treatment of TTP since the documentation of effectiveness of plasma exchange in 1991”. A refund up to 12 inpatient doses will also be offered for patients whose disease worsens while receiving treatment.

article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

Additionally, by collaborating with pharmaceutical companies and academic institutions, onsite specialty pharmacies can facilitate the development of novel therapies — and participate in research initiatives that ultimately benefit patient care for everyone. Fortunately, those steps tend to be the least burdensome in the process.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

Additionally, by collaborating with pharmaceutical companies and academic institutions, onsite specialty pharmacies can facilitate the development of novel therapies — and participate in research initiatives that ultimately benefit patient care for everyone. Fortunately, those steps tend to be the least burdensome in the process.

article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

Additionally, by collaborating with pharmaceutical companies and academic institutions, onsite specialty pharmacies can facilitate the development of novel therapies — and participate in research initiatives that ultimately benefit patient care for everyone. Fortunately, those steps tend to be the least burdensome in the process.